Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Acromegaly market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Acromegalymarket, defines the market attractiveness level of Acromegaly market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Acromegaly industry, describes the types of Acromegaly market, the applications of major players and the market size, and deeply analyzes the current situation of the global Acromegaly market and the development prospects and opportunities of Acromegaly industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Acromegaly market in Chapter 13.
By Player:
Novartis
Glide Pharmaceutical
Chiasma
Aegis Therapeutics
Foresee Pharmaceuticals
Amryt Pharma
Silence Therapeutics
Daewoong Pharmaceutical
Strongbridge Biopharma
Ipsen
Crinetics Pharmaceuticals
Peptron
Ionis Pharmaceuticals
By Type:
Somatostatin Analogues
Dopamine Agonists
Growth Hormone Receptor Antagonists
Other
By End-User:
Hospitals
Clinics
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Acromegaly Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Acromegaly Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Acromegaly Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Acromegaly Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Acromegaly Market Analysis and Outlook to 2022
-
7.1 Global Acromegaly Consumption (2017-2022)
-
7.2 United States Acromegaly Consumption (2017-2022)
-
7.3 Europe Acromegaly Consumption (2017-2022)
-
7.4 China Acromegaly Consumption (2017-2022)
-
7.5 Japan Acromegaly Consumption (2017-2022)
-
7.6 India Acromegaly Consumption (2017-2022)
-
7.7 South Korea Acromegaly Consumption (2017-2022)
8 Region and Country-wise Acromegaly Market Analysis and Outlook to 2028
-
8.1 Global Acromegaly Consumption Forecast (2022-2028)
-
8.2 United States Acromegaly Consumption Forecast (2022-2028)
-
8.3 Europe Acromegaly Consumption Forecast (2022-2028)
-
8.4 China Acromegaly Consumption Forecast (2022-2028)
-
8.5 Japan Acromegaly Consumption Forecast (2022-2028)
-
8.6 India Acromegaly Consumption Forecast (2022-2028)
-
8.7 South Korea Acromegaly Consumption Forecast (2022-2028)
9 Global Acromegaly Market Outlook by Types and Applications to 2022
-
9.1 Global Acromegaly Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Somatostatin Analogues Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Dopamine Agonists Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Growth Hormone Receptor Antagonists Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Acromegaly Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
10 Global Acromegaly Market Outlook by Types and Applications to 2028
-
10.1 Global Acromegaly Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Somatostatin Analogues Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Dopamine Agonists Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Growth Hormone Receptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Acromegaly Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
11 Global Acromegaly Import and Export Analysis (Top 5 Countries)
-
11.1 Global Acromegaly Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Acromegaly Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Acromegaly Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Acromegaly Market Competitive Analysis
-
14.1 Novartis
-
14.1.1 Novartis Company Details
-
14.1.2 Novartis Acromegaly Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis Acromegaly Product and Service
-
14.2 Glide Pharmaceutical
-
14.2.1 Glide Pharmaceutical Company Details
-
14.2.2 Glide Pharmaceutical Acromegaly Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Glide Pharmaceutical Acromegaly Product and Service
-
14.3 Chiasma
-
14.3.1 Chiasma Company Details
-
14.3.2 Chiasma Acromegaly Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Chiasma Acromegaly Product and Service
-
14.4 Aegis Therapeutics
-
14.4.1 Aegis Therapeutics Company Details
-
14.4.2 Aegis Therapeutics Acromegaly Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Aegis Therapeutics Acromegaly Product and Service
-
14.5 Foresee Pharmaceuticals
-
14.5.1 Foresee Pharmaceuticals Company Details
-
14.5.2 Foresee Pharmaceuticals Acromegaly Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Foresee Pharmaceuticals Acromegaly Product and Service
-
14.6 Amryt Pharma
-
14.6.1 Amryt Pharma Company Details
-
14.6.2 Amryt Pharma Acromegaly Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Amryt Pharma Acromegaly Product and Service
-
14.7 Silence Therapeutics
-
14.7.1 Silence Therapeutics Company Details
-
14.7.2 Silence Therapeutics Acromegaly Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Silence Therapeutics Acromegaly Product and Service
-
14.8 Daewoong Pharmaceutical
-
14.8.1 Daewoong Pharmaceutical Company Details
-
14.8.2 Daewoong Pharmaceutical Acromegaly Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Daewoong Pharmaceutical Acromegaly Product and Service
-
14.9 Strongbridge Biopharma
-
14.9.1 Strongbridge Biopharma Company Details
-
14.9.2 Strongbridge Biopharma Acromegaly Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Strongbridge Biopharma Acromegaly Product and Service
-
14.10 Ipsen
-
14.10.1 Ipsen Company Details
-
14.10.2 Ipsen Acromegaly Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Ipsen Acromegaly Product and Service
-
14.11 Crinetics Pharmaceuticals
-
14.11.1 Crinetics Pharmaceuticals Company Details
-
14.11.2 Crinetics Pharmaceuticals Acromegaly Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Crinetics Pharmaceuticals Acromegaly Product and Service
-
14.12 Peptron
-
14.12.1 Peptron Company Details
-
14.12.2 Peptron Acromegaly Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Peptron Acromegaly Product and Service
-
14.13 Ionis Pharmaceuticals
-
14.13.1 Ionis Pharmaceuticals Company Details
-
14.13.2 Ionis Pharmaceuticals Acromegaly Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Ionis Pharmaceuticals Acromegaly Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Acromegaly
-
Figure Acromegaly Picture
-
Table Global Acromegaly Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Acromegaly Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Acromegaly Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Acromegaly Consumption by Country (2017-2022)
-
Figure United States Acromegaly Consumption and Growth Rate (2017-2022)
-
Table Europe Acromegaly Consumption and Growth Rate (2017-2022)
-
Figure China Acromegaly Consumption and Growth Rate (2017-2022)
-
Figure Japan Acromegaly Consumption and Growth Rate (2017-2022)
-
Figure India Acromegaly Consumption and Growth Rate (2017-2022)
-
Figure South Korea Acromegaly Consumption and Growth Rate (2017-2022)
-
Figure Global Acromegaly Consumption Forecast by Country (2022-2028)
-
Figure United States Acromegaly Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Acromegaly Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Acromegaly Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Acromegaly Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Acromegaly Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Acromegaly Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Somatostatin Analogues Consumption and Growth Rate (2017-2022)
-
Figure Global Dopamine Agonists Consumption and Growth Rate (2017-2022)
-
Figure Global Growth Hormone Receptor Antagonists Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Somatostatin Analogues Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dopamine Agonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Growth Hormone Receptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Acromegaly Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Acromegaly Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Acromegaly Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Acromegaly Product and Service
-
Table Glide Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Glide Pharmaceutical Acromegaly Sales, Price, Value and Gross Profit (2017-2022)
-
Table Glide Pharmaceutical Acromegaly Product and Service
-
Table Chiasma (Foundation Year, Company Profile and etc.)
-
Table Chiasma Acromegaly Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chiasma Acromegaly Product and Service
-
Table Aegis Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Aegis Therapeutics Acromegaly Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aegis Therapeutics Acromegaly Product and Service
-
Table Foresee Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Foresee Pharmaceuticals Acromegaly Sales, Price, Value and Gross Profit (2017-2022)
-
Table Foresee Pharmaceuticals Acromegaly Product and Service
-
Table Amryt Pharma (Foundation Year, Company Profile and etc.)
-
Table Amryt Pharma Acromegaly Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amryt Pharma Acromegaly Product and Service
-
Table Silence Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Silence Therapeutics Acromegaly Sales, Price, Value and Gross Profit (2017-2022)
-
Table Silence Therapeutics Acromegaly Product and Service
-
Table Daewoong Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Daewoong Pharmaceutical Acromegaly Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daewoong Pharmaceutical Acromegaly Product and Service
-
Table Strongbridge Biopharma (Foundation Year, Company Profile and etc.)
-
Table Strongbridge Biopharma Acromegaly Sales, Price, Value and Gross Profit (2017-2022)
-
Table Strongbridge Biopharma Acromegaly Product and Service
-
Table Ipsen (Foundation Year, Company Profile and etc.)
-
Table Ipsen Acromegaly Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ipsen Acromegaly Product and Service
-
Table Crinetics Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Crinetics Pharmaceuticals Acromegaly Sales, Price, Value and Gross Profit (2017-2022)
-
Table Crinetics Pharmaceuticals Acromegaly Product and Service
-
Table Peptron (Foundation Year, Company Profile and etc.)
-
Table Peptron Acromegaly Sales, Price, Value and Gross Profit (2017-2022)
-
Table Peptron Acromegaly Product and Service
-
Table Ionis Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Ionis Pharmaceuticals Acromegaly Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ionis Pharmaceuticals Acromegaly Product and Service
-
